Syed Abdullah Javaid Bukhari, Medical Oncologist at GMC and SCFHS, shared a post on LinkedIn:
“Pleased to share our recent publication in Cureus on Stage IIIC poor-risk testicular germ cell tumors.
Working on this cohort highlighted a difficult reality—high early mortality and relapse rates persist, despite this being a largely curable disease overall.
Our findings emphasize the prognostic value of tumor marker normalization and the need for better treatment strategies in this high-risk group.
Grateful to my co-authors and team for their contribution.”
Title: Clinical Outcomes of Stage IIIC Poor-Risk Testicular Germ Cell Tumors: A Retrospective Analysis From a Tertiary Care Center
Authors: Maryam Imran, Shehar Bano, Afshan Khanum, and Syed Abdullah Javaid Bukhari
Read the article here.”
Other articles about testicular cancer on OncoDaily.